The tariff classification of MLN608, imported in bulk and measured-dose forms, for use in Phase 1 clinical trials, from the United Kingdom and Canada
Reasoning
The tariff classification of MLN608, imported in bulk and measured-dose forms, for use in Phase 1 clinical trials, from the United Kingdom and Canada
Cite this ruling
CBP Ruling J83524 (2933993900): The tariff classification of MLN608, imported in bulk and measured-dose forms, for use in Phase 1 clinical trials, from the United Kingdom and Canada
Paste this into a product's override reason when citing this ruling as justification for a classification.
Other rulings for HS6 293399
The tariff classification of Amisulpride (CAS-71675-85-9) in bulk powder form, from Italy
The tariff classification of Temozolomide (CAS-85622-93-1) in bulk form, from China
The tariff classification of 1-Methylhomopiperazine, CAS No. 4318-37-0, imported in bulk form, from China
The tariff classification of 1-(2-Nitrophenylmethyl)-2-pyrrolecarboxaldehyde, CAS No. 22162-51-2, imported in bulk form, from India
The tariff classification of chemical reagents from Korea